Tag: clinical trials

Randomized controlled trials of psilocybin-assisted therapy for alcohol and tobacco addiction have produced some of the most remarkable effect sizes seen in addiction medicine research. This detailed review examines what these trials actually found, their methodological strengths and limitations, and what they mean for future treatment.

Psychedelic therapy research is undergoing a renaissance, with rigorous clinical trials demonstrating that compounds like psilocybin and MDMA may offer breakthrough treatment for addiction. Learn what the science actually shows and how these findings may shape future care.